Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Total 13F shares
-
70,190,994
-
Share change
-
+951,179
-
Total reported value
-
$436,594,924
-
Price per share
-
$6.22
-
Number of holders
-
120
-
Value change
-
-$9,658,535
-
Number of buys
-
72
-
Number of sells
-
39
Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q4 2021
As of 31 Dec 2021,
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,190,994 shares.
The largest 10 holders included
BlackRock Inc., Avoro Capital Advisors LLC, Bain Capital Life Sciences Investors, LLC, WELLINGTON MANAGEMENT GROUP LLP, Sarissa Capital Management LP, STATE STREET CORP, Bellevue Group AG, VANGUARD GROUP INC, Rock Springs Capital Management LP, and ORBIMED ADVISORS LLC.
This page lists
120
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.